Division of Hematology/Oncology

Share This Page:

Martin Peter Carroll, MD

faculty photo
Associate Professor of Medicine
Attending Physician, Hematology Consult Service, 1 mo./yr., Hospital of the University of Pennsylvania
Attending Physician, West Philadelphia Veterans Administration Hospital
Department: Medicine

Contact information
Room 715, BRB II/III
421 Curie Blvd.
Philadelphia, PA 19104
Office: (215) 573-5217
Fax: (215) 573-7049
Graduate Group Affiliations
Education:
A.B. (English and American Literature)
Harvard College, Cambridge, MA, 1982.
M.D. (Medicine)
Dartmouth Medical School, Hanover, NH, 1988.
Post-Graduate Training
Intern in Medicine , Columbia-Presbyterian Medical Center, New York, 1988-1989.
Resident in Medicine , Columbia-Presbyterian Medical Center, New York, 1990-1991.
Clinical Fellowship, Hematology and Oncology , Beth Israel Hospital, Boston, 1991-1992.
Research Fellow, Laboratory of Dr. Alan D'Andrea, Dana-Farber , Cancer Institute, Boston, MA, 1992-1995.
Research Fellow, Laboratory of Dr. D. Gary Gilliland, , Brigham and Women's Hospital, Boston, MA, 1995-1998.
Certifications
American Board of Internal Medicine, 1991.
Medical Oncology Subspecialty Certification, 1993.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Leukemia and myelodysplastic syndromes

Selected Publications

Hurtz Christian, Wertheim Gerald B, Loftus Joseph P, Blumenthal Daniel, Lehman Anne, Li Yong, Bagashev Asen, Manning Bryan, Cummins Katherine D, Burkhardt Janis K, Perl Alexander E, Carroll Martin, Tasian Sarah K: Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALL. The Journal of clinical investigation Mar 2020.

Abshiru, N. A., Sikora, J. W., Camarillo, J. M., Morris, J. A., Compton, P. D., Lee, T., Neelamraju, Y., Haddox, S., Sheridan, C., Carroll, M., Cripe, L. D., Tallman, M. S., Paietta, E. M., Melnick, A. M., Thomas, P. M., Garrett-Bakelman, F. E., Kelleher, N. L.: Targeted detection and quantitation of histone modifications from 1,000 cells. PLoS One 15(10): e0240829, 2020.

Carroll, M.: A common protein target for an uncommon subtype of AML. Blood 136(4): 377-378, 2020.

Miles, L. A., Bowman, R. L., Merlinsky, T. R., Csete, I. S., Ooi, A. T., Durruthy-Durruthy, R., Bowman, M., Famulare, C., Patel, M. A., Mendez, P., Ainali, C., Demaree, B., Delley, C. L., Abate, A. R., Manivannan, M., Sahu, S., Goldberg, A. D., Bolton, K. L., Zehir, A., Rampal, R., Carroll, M. P., Meyer, S. E., Viny, A. D., Levine, R. L.: Single-cell mutation analysis of clonal evolution in myeloid malignancies. Nature 2020.

Fagnan, A., Bagger, F. O., Piqué-Borràs, M. R., Ignacimouttou, C., Caulier, A., Lopez, C. K., Robert, E., Uzan, B., Gelsi-Boyer, V., Aid, Z., Thirant, C., Moll, U., Tauchmann, S., Kurtovic-Kozaric, A., Maciejewski, J., Dierks, C., Spinelli, O., Salmoiraghi, S., Pabst, T., Shimoda, K., Deleuze, V., Lapillonne, H., Sweeney, C., De Mas, V., Leite, B., Kadri, Z., Malinge, S., de Botton, S., Micol, J. B., Kile, B., Carmichael, C. L., Iacobucci, I., Mullighan, C. G., Carroll, M., Valent, P., Bernard, O. A., Delabesse, E., Vyas, P., Birnbaum, D., Anguita, E., Garçon, L., Soler, E., Schwaller, J., Mercher, T.: Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers. Blood 136(6): 698-714, 2020.

Cai, Z., Aguilera, F., Ramdas, B., Daulatabad, S. V., Srivastava, R., Kotzin, J. J., Carroll, M., Wertheim, G., Williams, A., Janga, S. C., Zhang, C., Henao-Mejia, J., Kapur, R.: Targeting Bim via a lncRNA Morrbid Regulates the Survival of Preleukemic and Leukemic Cells. Cell Rep 31(12): 107816, 2020.

Kawabata, K. C., Zong, H., Meydan, C., Wyman, S., Wouters, B. J., Sugita, M., Goswami, S., Albert, M., Yip, W., Roboz, G. J., Chen, Z., Delwel, R., Carroll, M. P., Mason, C., Melnick, A., Guzman, M. L.: BCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cells. Blood 2020.

McMahon Christine M, Canaani Jonathan, Rea Bryan, Sargent Rachel L, Qualtieri Julianne N, Watt Christopher D, Morrissette Jennifer J D, Carroll Martin, Perl Alexander E: Gilteritinib induces differentiation in relapsed and refractory -mutated acute myeloid leukemia. Blood advances 3(10): 1581-1585, May 2019.

Duy Cihangir, Teater Matt, Garrett-Bakelman Francine E, Lee Tak C, Meydan Cem, Glass Jacob L, Li Meng, Hellmuth Johannes C, Mohammad Helai P, Smitheman Kimberly N, Shih Alan H, Abdel-Wahab Omar, Tallman Martin S, Guzman Monica L, Muench David, Grimes H Leighton, Roboz Gail J, Kruger Ryan G, Creasy Caretha L, Paietta Elisabeth M, Levine Ross L, Carroll Martin, Melnick Ari M: Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AML. Cancer discovery 9(7): 872-889, May 2019.

McMahon Christine M, Ferng Timothy, Canaani Jonathan, Wang Eunice S, Morrissette Jennifer Jd, Eastburn Dennis J, Pellegrino Maurizio, Durruthy-Durruthy Robert, Watt Christopher D, Asthana Saurabh, Lasater Elisabeth A, DeFilippis RosaAnna, Peretz Cheryl A C, McGary Lisa H F, Deihimi Safoora, Logan Aaron C, Luger Selina M, Shah Neil P, Carroll Martin, Smith Catherine C, Perl Alexander E: Clonal selection with Ras pathway activation mediates secondary clinical resistance to selective FLT3 inhibition in acute myeloid leukemia. Cancer discovery 9(8): 1050-1063, May 2019.

back to top
Last updated: 11/03/2020
The Trustees of the University of Pennsylvania